SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Saliva Diagnostics (SALV)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Eric Winterhalder who wrote (2119)2/18/1998 10:44:00 AM
From: rl   of 3369
 
Thank you very much for the explanation. Your scenario is more than plausible for SALV. It is almost surely the fact. If anyone has followed the history of SALV since its' public beginning (I have), you will see that the three financings done as Reg S (2) and Reg D (1) resulted in approximately the outcome that Eric poses. Large short positions were established, big chunks of stock hit, the price tumbled and the only winners were the so-called investors. These "investors" do not give a hoot for the company. In fact, just the opposite. The play is for the stock price to go down. If you read the SALV filings, they have been involved in a lawsuit for years that addresses just this question (Meritxell).
Question: Since McLachlan was the highly paid CFO, the second in command at SALV, for almost one year before he "fired" the CEO and a BOD member for almost two years before, does he include himself as one of the "bad guys?" Why hasn't the company disclosed the supposed shenanigans? Don't they think it's "material?" I think these excuses are only dusted off when the blame needs to be passed. Let's see the proof. Otherwise, shut up and do business properly if capable.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext